Clinical Trial Update: Artemisone for the Treatment of Uncomplicated Falciparum Malaria in Western Cambodia [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update indicates Artemisone for uncomplicated falciparum malaria has been withdrawn (Phase 2/Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uncomplicated Malaria Due to Plasmodium Falciparum

Drugs mentioned

• Artemisone (Artemisone)

Snippet

Sponsor: University of Oxford | Conditions: Uncomplicated Falciparum Malaria | Phase 2, Phase 3 | Status: WITHDRAWN